Returns on pharmaceutical R&D improving as pipelines revive
December 09, 2014 at 19:01 PM EST
LONDON, Dec 10 (Reuters) - Drugmakers are finally getting more bang for their scientific buck, with the rate of return on pharmaceutical research and development (R&D) increasing for the first time since 2010.